Development and validation of AI/ML derived splice-switching oligonucleotides

Overview of attention for article published in Molecular Systems Biology, April 2024

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
One of the highest-scoring outputs from this source (#8 of 1,157)
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (90th percentile)

So far, Altmetric has seen 28 news stories from 28 outlets.

NEW YORK — NEW YORK, April 25, 2024 /PRNewswire/ -- Envisagenics, an AI-driven biotechnology company, today announced the…

Envisagenics Validates AI/ML Approach for RNA Target Identification and SSO Therapeutic Development PR Newswire NEW YORK, April…

Results from evaluation of the company's SpliceCore® AI/ML platform in Triple Negative Breast Cancer published in Molecular…

Results from evaluation of the company's SpliceCore® AI/ML platform in Triple Negative Breast Cancer published in Molecular…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity, including 24 additional news stories.